JP2023543993A5 - - Google Patents
Info
- Publication number
- JP2023543993A5 JP2023543993A5 JP2023519016A JP2023519016A JP2023543993A5 JP 2023543993 A5 JP2023543993 A5 JP 2023543993A5 JP 2023519016 A JP2023519016 A JP 2023519016A JP 2023519016 A JP2023519016 A JP 2023519016A JP 2023543993 A5 JP2023543993 A5 JP 2023543993A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- hht
- alkyl
- subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2015536.2 | 2020-09-30 | ||
| GB2015536.2A GB2600384A (en) | 2020-09-30 | 2020-09-30 | Allosteric AKT inhibitors for use in the treatment of hereditary hemorrhagic telangiectasia |
| PCT/EP2021/076811 WO2022069552A1 (en) | 2020-09-30 | 2021-09-29 | Allosteric akt inhibitors for use in the treatment of hereditary hemorrhagic telangiectasia |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023543993A JP2023543993A (ja) | 2023-10-19 |
| JP2023543993A5 true JP2023543993A5 (https=) | 2024-10-04 |
Family
ID=73197201
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023519016A Pending JP2023543993A (ja) | 2020-09-30 | 2021-09-29 | 遺伝性出血性毛細血管拡張症の治療における使用のためのアロステリックａｋｔ阻害剤 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US12466839B2 (https=) |
| EP (1) | EP4221713A1 (https=) |
| JP (1) | JP2023543993A (https=) |
| KR (1) | KR20230080448A (https=) |
| CN (1) | CN116419924A (https=) |
| AU (1) | AU2021352108B2 (https=) |
| BR (1) | BR112023004885A2 (https=) |
| CA (1) | CA3192433A1 (https=) |
| CL (1) | CL2023000926A1 (https=) |
| GB (1) | GB2600384A (https=) |
| IL (1) | IL301466A (https=) |
| MX (1) | MX2023002996A (https=) |
| WO (1) | WO2022069552A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2600384A (en) | 2020-09-30 | 2022-05-04 | Vaderis Therapeutics Ag | Allosteric AKT inhibitors for use in the treatment of hereditary hemorrhagic telangiectasia |
| WO2026038045A1 (en) | 2024-08-15 | 2026-02-19 | Almac Discovery Limited | Crystalline forms of 6-(4-((1s,3s)-1-amino-3-hydroxycyclobutyl)phenyl)-1-ethyl-7-phenyl-1h-pyrido[2,3-b][1,4]oxazin-2(3h)-one salts and free base |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI301760B (en) | 2004-02-27 | 2008-10-11 | Merz Pharma Gmbh & Co Kgaa | Tetrahydroquinolinones and their use as antagonists of metabotropic glutamate receptors |
| US7910561B2 (en) | 2004-12-15 | 2011-03-22 | Merck Sharp & Dohme Corp. | Inhibitors of Akt activity |
| EP1898903B8 (en) | 2005-06-10 | 2013-05-15 | Merck Sharp & Dohme Corp. | Inhibitors of akt activity |
| WO2008011032A1 (en) | 2006-07-17 | 2008-01-24 | Amgen Inc. | Quinazoline and pyridopyrimidine derivatives as p38 kinase inhibitors |
| AR064010A1 (es) | 2006-12-06 | 2009-03-04 | Merck & Co Inc | Inhibidores de la actividad de la akt |
| JP2010512312A (ja) | 2006-12-06 | 2010-04-22 | メルク エンド カムパニー インコーポレーテッド | Ａｋｔ活性の阻害剤 |
| US7999107B2 (en) | 2007-01-31 | 2011-08-16 | Merck Sharp & Dohme Corp. | Substituted pyrano[2,3-B]pyridine derivatives as cannabinoid-1 receptor modulators |
| JP2011522048A (ja) | 2008-06-03 | 2011-07-28 | メルク・シャープ・エンド・ドーム・コーポレイション | Ａｋｔ活性の阻害剤 |
| US8536193B2 (en) | 2008-06-03 | 2013-09-17 | Merck Sharp & Dohme Corp. | Inhibitors of AKT activity |
| EP2116237A1 (en) | 2008-08-05 | 2009-11-11 | Polichem SA | Compositions for treating rosacea comprising chitosan and a dicarboxylic acid |
| EA201101186A1 (ru) | 2009-02-13 | 2012-04-30 | Байер Фарма Акциенгезельшафт | Конденсированные пиримидины |
| GB0922589D0 (en) | 2009-12-23 | 2010-02-10 | Almac Discovery Ltd | Pharmaceutical compounds |
| HUE026323T2 (en) | 2011-04-07 | 2016-05-30 | Bayer Ip Gmbh | Imidazopyridazines as akt kinase inhibitors |
| EP3294314A4 (en) | 2015-05-15 | 2019-01-16 | Memorial Sloan Kettering Cancer Center | USE OF PHOPHOINOSITIDE-3-KINASE INHIBITORS FOR THE TREATMENT OF VASCULAR DISEASES |
| MX2020002611A (es) | 2017-09-07 | 2020-07-13 | Univ Res Inst Inc Augusta | Activador especifico de akt3 y usos del mismo. |
| GB2600384A (en) | 2020-09-30 | 2022-05-04 | Vaderis Therapeutics Ag | Allosteric AKT inhibitors for use in the treatment of hereditary hemorrhagic telangiectasia |
-
2020
- 2020-09-30 GB GB2015536.2A patent/GB2600384A/en not_active Withdrawn
-
2021
- 2021-09-29 KR KR1020237014688A patent/KR20230080448A/ko active Pending
- 2021-09-29 WO PCT/EP2021/076811 patent/WO2022069552A1/en not_active Ceased
- 2021-09-29 AU AU2021352108A patent/AU2021352108B2/en active Active
- 2021-09-29 BR BR112023004885A patent/BR112023004885A2/pt unknown
- 2021-09-29 CN CN202180066598.2A patent/CN116419924A/zh active Pending
- 2021-09-29 CA CA3192433A patent/CA3192433A1/en active Pending
- 2021-09-29 JP JP2023519016A patent/JP2023543993A/ja active Pending
- 2021-09-29 EP EP21789616.6A patent/EP4221713A1/en active Pending
- 2021-09-29 US US18/247,261 patent/US12466839B2/en active Active
- 2021-09-29 IL IL301466A patent/IL301466A/en unknown
- 2021-09-29 MX MX2023002996A patent/MX2023002996A/es unknown
-
2023
- 2023-03-29 CL CL2023000926A patent/CL2023000926A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023527575A5 (https=) | ||
| JP2024050527A5 (https=) | ||
| JP2024514837A5 (https=) | ||
| JP2023543993A5 (https=) | ||
| JP2006515310A5 (https=) | ||
| JP2022520061A5 (https=) | ||
| RU2004104625A (ru) | Аналоги простагландинов в качестве агонистов рецептора ep4 | |
| JP2017531020A5 (https=) | ||
| JP2021514001A5 (https=) | ||
| JP2011509309A5 (https=) | ||
| JP2020075939A5 (https=) | ||
| JP2024516033A5 (https=) | ||
| JP2023535815A5 (https=) | ||
| JP2023533203A5 (https=) | ||
| JP2014518554A (ja) | スフィンゴシン−１リン酸受容体調節剤としての置換二環式メチルアミン誘導体 | |
| JP5643213B2 (ja) | 肥大性心筋症治療用のホスホジエステラーゼタイプＩＩＩ（ＰＤＥＩＩＩ）インヒビターまたはＣａ２＋感作剤 | |
| JP2023504542A5 (https=) | ||
| JP2013542267A5 (https=) | ||
| JP2024546678A5 (https=) | ||
| JP2023553428A5 (https=) | ||
| JP2009501745A5 (https=) | ||
| JP2009526834A5 (https=) | ||
| JP6488000B2 (ja) | ２−シアノ−３−シクロプロピル−３−ヒドロキシ−ｎ−アリール−チオアクリルアミド誘導体 | |
| JP2006516643A5 (https=) | ||
| JP2022548158A5 (https=) |